NCT05126407View on ClinicalTrials.gov

A Study of Olynth Saline/Ectomed Nasal Drops/Spray Based Upon Previous Usage

CompletedOBSERVATIONAL
Enrollment

87

Participants

Timeline

Start Date

December 17, 2021

Primary Completion Date

January 20, 2022

Study Completion Date

January 20, 2022

Conditions
Common ColdSinusitisHypersensitivity
Trial Locations (1)

D-10789

Schlesinger Group, Berlin

All Listed Sponsors
lead

Johnson & Johnson Consumer Inc. (J&JCI)

INDUSTRY

NCT05126407 - A Study of Olynth Saline/Ectomed Nasal Drops/Spray Based Upon Previous Usage | Biotech Hunter | Biotech Hunter